Recent studies identified MCT4 as a heteromeric transporter composed of a catalytic a-subunit (MCT) and an accessory h-subunit (CD147),which was identified as an extracellular matrix metalloproteinase inducer in cancer cells [23], and subsequently found to be expressed at high levels in metastatic tumor cells [24]. This evidence concerns the gene BSG and cancer.